Biotech





Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Can-Fite BioPharma Ltd. (CANF) Buy Target $1.17 – Sell Target $1.65

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company’s lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical […]

Read More
Biotech
One Hot Stock
Pest Control
TradersPro Alerts

SenesTech, Inc. (SNES) Buy Target $1.25 – Sell Target $2.16

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

Galmed Pharmaceuticals Ltd. (GLMD) Buy Target $9.04 – Sell Target $13.62

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. The company is develops Aramchol, an oral therapy, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. […]

Read More
Biotech
One Hot Stock
TradersPro Alerts

Immutep Limited (IMMP) – Buy Target $2.35 Sell Target $3.28

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced its participation in various upcoming industry conferences. The Company will be presenting updated clinical data from the Phase I TACTI-mel trial in metastatic melanoma for its lead product candidate eftilagimod alpha […]

Read More
Biotech
Stock Picks

2 Tiny Biotechs With Massive Growth Potential

Both of these 2 biotechs could see triple-digit gains on the horizon. Here’s why.

Read More
Biotech
One Hot Stock
Pet Therapeutics
TradersPro Alerts

Aratana Therapeutics, Inc. (PETX)

Aratana Therapeutics, Inc., a pet therapeutics company, focuses on the licensing, development, and commercialization of therapeutics for dogs and cats in the United States and Belgium. Its product portfolio includes multiple therapeutics and therapeutic candidates in development consisting of small molecule pharmaceuticals and biologics. The company markets ENTYCE for appetite stimulation in dogs; GALLIPRANT for […]

Read More
Biopharmaceuticals
Biotech
One Hot Stock
TradersPro Alerts

vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company’s drug candidates comprise azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase III clinical trials for the treatment of Alzheimer’s disease.  Annual EPS Growth – Companies […]

Read More
Biotech

Biotechs Are Breaking Out – Here Are 2 That Should Be On Your Radar Now

Biotechs are on a roll this year. The IBB, an ETF that tracks the sector’s biggest players, is up nearly 14% this month—its best monthly performance in more than 2 years—almost double the S&P 500’s year-to-date (YTD) performance of 7.7%. But investing in biotechs can be tricky business as stocks can go from boom to […]

Read More
Biotech
Pharmaceuticals
TradersPro Alerts

Antares Pharma, Inc. (ATRS)

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Sumatriptan Injection USP for the acute […]

Read More